Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sarcoma × plerixafor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 29 Lymphoma, Non-Hodgkin 27 Leukemia, Myeloid, Acute 20 Hodgkin Disease 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 10 Leukemia, Lymphocytic, Chronic, B-Cell 9 Lymphoma 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia 4 Pancreatic Neoplasms 3 Neoplasms, Plasma Cell 3 Lymphoma, Mantle-Cell 3 Lymphoma, Follicular 3 Hematologic Neoplasms 3 Gliosarcoma 3 Glioblastoma 3 Warts 2 Sezary Syndrome 2 Neutropenia 2 Myeloproliferative Disorders 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Hairy Cell 2 Infections 2 Immunologic Deficiency Syndromes 2 Glioma 2

Interventions

Doxorubicin 123 Ifosfamide 72 Radiotherapy 65 Cyclophosphamide 62 Gemcitabine 54 Filgrastim 47 pazopanib 35 Docetaxel 35 pembrolizumab 34 Etoposide 33 Vincristine 31 Trabectedin 31 Cisplatin 30 Nivolumab 27 Magnetic Resonance Spectroscopy 22 Irinotecan 21 Carboplatin 20 Ipilimumab 19 Temozolomide 17 Radiation 17 Bevacizumab 17 Mesna 16 Melphalan 16 Granulocyte Colony-Stimulating Factor 16 Biopsy 16 Specimen Handling 15 Sirolimus 15 Dactinomycin 15 eribulin 14 Topotecan 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03240861 2023-11-01

NYESO SCT

Jonsson Comprehensive Cancer Center

Phase 1 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡